InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the “Global Nanopore Sequencing Market– (By Product (Instruments, Consumables), By Type of Nanopore (Solid State, Biological, Hybrid), By Type of Nucleotide Sequenced (DNA, RNA), By Application, By End-user, By Region, Trends, Industry Competition Analysis, Revenue and Forecast To 2034.”
According to the latest research by InsightAce Analytic, the Global Nanopore Sequencing Market is valued at USD 343.0 Mn in 2024, and it is expected to reach USD 1,949.5 Mn by 2034 , with a CAGR of 19.4 % during the forecast period of 2025-2034.
Check this Report Brochure : https://www.insightaceanalytic.com/request-sample/3033
Nanopore sequencing represents a cutting-edge DNA sequencing technology that detects variations in electrical current as DNA or RNA molecules traverse a protein nanopore embedded in a membrane. Distinct from traditional sequencing methods, this technology does not require nucleic acid amplification or labeling, thereby enabling real-time, long-read sequencing capabilities. It is especially advantageous for the detection of complex genomic rearrangements and structural variants.
The nanopore sequencing market is witnessing robust growth, propelled by the increasing prevalence of genetic disorders worldwide and rising demand for long-read sequencing solutions applicable to both DNA and RNA analyses. The technology’s distinctive advantages—such as cost-effectiveness, immediate sequence detection, high precision, and the ability to identify nucleotide modifications—have driven its widespread adoption in research and clinical settings. Furthermore, market expansion is bolstered by the escalating utilization of sequencing consumables across diverse workflows, alongside the development of novel applications, including viral genome sequencing, which highlights the broad applicability and critical role of nanopore sequencing in contemporary genomics.
List of Prominent Players in the Nanopore Sequencing Market:
- Bio-Rad Laboratories, Inc.
- Danaher Corporation
- Pacific Biosciences
- Oxford Nanopore Technologies Limited
- QIAGEN
- Hoffmann-La Roche Ltd.
- PerkinElmer Inc.
- Thermo Fisher Scientific
- Eurofins Scientific
- Agilent Technologies, Inc.
- Myriad Genetics, Inc.
- Others
Market Dynamics
Drivers:
The nanopore sequencing market growth is significantly supported by considerable investments from both public and private sectors. The growing recognition of the technology’s transformative potential in personalized medicine and genomic research has led to increased funding aimed at enhancing the accuracy, efficiency, and accessibility of sequencing platforms. For example, in October 2023, French in vitro diagnostics company bioMérieux SA committed EUR 70 million in a strategic partnership with Oxford Nanopore Technologies. This collaboration focuses on advancing next-generation clinical diagnostics for genetic disorders and oncology by leveraging nanopore-based molecular sensing technologies. Such partnerships are strengthening the market positions of the involved companies while expediting the adoption of nanopore sequencing solutions.
Challenges:
Despite its promising capabilities, the high acquisition and operational costs associated with sequencing instruments and consumables continue to limit broader market penetration, particularly in low-resource environments. Although ongoing technological innovations are gradually lowering expenses, affordability remains a key concern for many potential end-users. Moreover, the requirement for specialized technical expertise to operate nanopore sequencing systems and analyze the resulting complex data represents an additional barrier. To sustain long-term growth, the development of cost-effective and user-friendly platforms will be critical.
Regional Trends:
North America is projected to retain a leading market share in nanopore sequencing, bolstered by the concentration of prominent industry players, substantial government funding, and a strong focus on research and development activities. The region benefits from advanced healthcare infrastructure and rapid adoption of cutting-edge sequencing technologies. The United States, in particular, is a global hub for genomic innovation, driven by significant investments in precision medicine and personalized healthcare initiatives. Meanwhile, the Asia-Pacific region is expected to experience the highest growth rate over the forecast period. This expansion is fueled by increasing awareness of advanced sequencing technologies, a growing emphasis on precision healthcare, and rising healthcare expenditures. Nations such as China, Japan, and India are making notable investments in genomic research and healthcare infrastructure, which are key drivers of nanopore sequencing adoption within the region.
Recent Development:
- September 2024: CycloneSEQ-WT02 and CycloneSEQ-WY01, two nanopore gene sequencing products, have been commercialized and distributed worldwide by MGI Tech Co., a Chinese firm. With a number of scientific advancements, including sophisticated protein engineering, a novel flow cell architecture, and a cutting-edge base calling algorithm, the CycloneSEQ technology exhibits promise in a variety of genomics domains. It is designed to achieve high sequencing accuracy and throughput.
- August 2024: Oxford Nanopore Technologies received an investment of GBP 50 million (USD 63 million) from Novo Holding. Through real-time workflows, Oxford Nanopore’s analytical technology is being utilized for DNA and RNA sequencing, giving users insights into the epigenetics of a material. This investment demonstrated Oxford Nanopore’s expanding potential in the biopharmaceutical industry and the company’s faith in its technology.
Segmentation of Nanopore Sequencing Market-
Nanopore Sequencing Market- By Product
- Instruments
- Consumables
Nanopore Sequencing Market- By Type of Nucleotide Sequenced
- DNA
- RNA
Nanopore Sequencing Market- By Type of Nanopore
- Solid State
- Biological
- Hybrid
Nanopore Sequencing Market- By Application
- Clinical Research
- Human Genetics
- Animal Research
- Others
Nanopore Sequencing Market- By End-User
- Clinical Laboratories
- Biotechnological Companies
- Academic & Research Institutes
- Others
Nanopore Sequencing Market- By Region
North America-
- The US
- Canada
Europe-
- Germany
- The UK
- France
- Italy
- Spain
- Rest of Europe
Asia-Pacific-
- China
- Japan
- India
- South Korea
- South East Asia
- Rest of Asia Pacific
Latin America-
- Brazil
- Mexico
- Rest of Latin America
Middle East & Africa-
- GCC Countries
- South Africa
- Rest of the Middle East and Africa
About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.
